Future studies including modulation of AKR1B1 expression in various myeloid cell types and coculture of these cells with CRC cells and investigation of the metabolic and transcriptomic changes might provide a deeper understanding of the mechanisms behind the current findings. This evidence concerns the gene AKR1B1 and colorectal carcinoma.